Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder - PubMed
Review
. 2013 Dec;43(12):1314-27.
doi: 10.1111/eci.12170. Epub 2013 Oct 14.
Affiliations
- PMID: 24117178
- DOI: 10.1111/eci.12170
Review
Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder
Piero Portincasa et al. Eur J Clin Invest. 2013 Dec.
Abstract
Background: Familial Mediterranean fever (FMF) is a rare inherited autosomal recessive autoinflammatory disorder characterized by recurrent and self-limited episodes of fever and painful serositis, lasting 1-3 days. FMF occurs almost exclusively among ethnic groups of the Mediterranean basin, although cases have also been found in Japan and Korean populations. Diagnosis is based on clinical features, response to colchicine and genetic analysis. Novel drugs are emerging, allowing better management of colchicine-resistant/colchicine-intolerant patients. This review aims to attract the attention of the readers on differential diagnosis and management of patients with FMF.
Methods: The current state-of-the-art on FMF is outlined, with respect to epidemiological, genetic, pathophysiological and therapeutic characteristics, based on critical analysis of solid scientific literature.
Results: FMF is more frequent than it was thought before. The phenotypic expression of M694V is more severe than that of V726A. Patients with M694V/M694V homozygosity are exposed to a higher risk of developing renal amyloidosis, arthritis, dermatologic and oral lesions, higher fever and more frequent painful attacks. Life-long therapy with colchicine (1·0-2·4 mg/day) is effective and safe to prevent recurrent attacks and renal amyloidosis and to reverse proteinuria. In nonresponder patients, alternative novel approaches include interleukin-1 receptor antagonist anakinra and the interleukin-1 decoy receptor rilonacept.
Conclusions: The prognosis of FMF is normal if AA amyloidosis is prevented. Colchicine remains the first-line therapy to treat pain and prevent amyloidosis. A follow-up should include clinical evaluation, therapeutic adjustments, measurement of serum amyloid A and proteinuria.
Keywords: Amyloidosis; anakinra; colchicine; periodic fever; pyrin; serositis.
© 2013 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.
Similar articles
-
[Familial Mediterranean Fever (FMF): from diagnosis to treatment].
Medlej-Hashim M, Loiselet J, Lefranc G, Mégarbané A. Medlej-Hashim M, et al. Sante. 2004 Oct-Dec;14(4):261-6. Sante. 2004. PMID: 15745878 Review. French.
-
Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics.
Grattagliano I, Bonfrate L, Ruggiero V, Scaccianoce G, Palasciano G, Portincasa P. Grattagliano I, et al. Clin Pharmacol Ther. 2014 Jan;95(1):89-97. doi: 10.1038/clpt.2013.148. Epub 2013 Jul 18. Clin Pharmacol Ther. 2014. PMID: 23867542 Review.
-
Familial Mediterranean fever, review of the literature.
Alghamdi M. Alghamdi M. Clin Rheumatol. 2017 Aug;36(8):1707-1713. doi: 10.1007/s10067-017-3715-5. Epub 2017 Jun 18. Clin Rheumatol. 2017. PMID: 28624931 Review.
-
The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever.
Calligaris L, Marchetti F, Tommasini A, Ventura A. Calligaris L, et al. Eur J Pediatr. 2008 Jun;167(6):695-6. doi: 10.1007/s00431-007-0547-3. Epub 2007 Jun 23. Eur J Pediatr. 2008. PMID: 17588171 Free PMC article.
-
Familial Mediterranean fever in childhood: a single-center experience.
Barut K, Sahin S, Adrovic A, Sinoplu AB, Yucel G, Pamuk G, Aydın AK, Dasdemir S, Turanlı ET, Buyru N, Kasapcopur O. Barut K, et al. Rheumatol Int. 2018 Jan;38(1):67-74. doi: 10.1007/s00296-017-3796-0. Epub 2017 Aug 21. Rheumatol Int. 2018. PMID: 28828621
Cited by
-
Colchicine--Update on mechanisms of action and therapeutic uses.
Leung YY, Yao Hui LL, Kraus VB. Leung YY, et al. Semin Arthritis Rheum. 2015 Dec;45(3):341-50. doi: 10.1016/j.semarthrit.2015.06.013. Epub 2015 Jun 26. Semin Arthritis Rheum. 2015. PMID: 26228647 Free PMC article. Review.
-
Carroccio A, Mansueto P, Soresi M, Fayer F, Di Liberto D, Monguzzi E, Lo Pizzo M, La Blasca F, Geraci G, Pecoraro A, Dieli F, Schuppan D. Carroccio A, et al. Nutrients. 2020 Apr 17;12(4):1127. doi: 10.3390/nu12041127. Nutrients. 2020. PMID: 32316660 Free PMC article.
-
Screening of Free Carnitine and Acylcarnitine Status in Children With Familial Mediterranean Fever.
Kiykim E, Aktuğlu Zeybek AÇ, Barut K, Zübarioğlu T, Cansever MŞ, Alsancak Ş, Kasapçopur Ö. Kiykim E, et al. Arch Rheumatol. 2016 Mar 10;31(2):133-138. doi: 10.5606/ArchRheumatol.2016.5696. eCollection 2016 Jun. Arch Rheumatol. 2016. PMID: 29900937 Free PMC article.
-
Yilmaz H, Inan O, Darcin T, Bilgic MA, Akcay A. Yilmaz H, et al. Clin Exp Nephrol. 2015 Jun;19(3):436-42. doi: 10.1007/s10157-014-1009-7. Epub 2014 Jul 25. Clin Exp Nephrol. 2015. PMID: 25059227
-
Uslu AU, Aydin B, Icagasıoğlu IS, Balta S, Deveci K, Alkan F, Yıldız G, Sahin A. Uslu AU, et al. J Clin Lab Anal. 2016 Nov;30(6):1003-1008. doi: 10.1002/jcla.21971. Epub 2016 Apr 19. J Clin Lab Anal. 2016. PMID: 27094695 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources